Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.49%
|
$4,988
$43.7 P/Share
|
|
Mar 17
2025
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,500
-15.07%
|
$150,500
$43.16 P/Share
|
|
Mar 15
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
525
-1.36%
|
$22,050
$42.89 P/Share
|
|
Mar 15
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+2.57%
|
-
|
|
Mar 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+6.96%
|
-
|
|
Mar 15
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-1.61%
|
$21,000
$42.89 P/Share
|
|
Mar 15
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,401
+4.32%
|
-
|
|
Mar 15
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-0.96%
|
$16,254
$42.89 P/Share
|
|
Mar 15
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,401
+3.37%
|
-
|
|
Mar 15
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-0.97%
|
$9,576
$42.89 P/Share
|
|
Mar 15
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+2.64%
|
-
|
|
Mar 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.49%
|
-
|
|
Mar 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-4.04%
|
$69,678
$42.89 P/Share
|
|
Mar 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+3.9%
|
-
|
|
Mar 14
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,853
-1.43%
|
$1,463,826
$42.89 P/Share
|
|
Mar 14
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,769
+2.75%
|
-
|
|
Mar 14
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,853
-1.5%
|
$1,463,826
$42.89 P/Share
|
|
Mar 14
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,769
+2.87%
|
-
|
|
Mar 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+0.86%
|
-
|
|
Mar 03
2025
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
100
-1.29%
|
$4,200
$42.71 P/Share
|
|
Mar 01
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,565
-24.48%
|
$275,730
$42.55 P/Share
|
|
Mar 01
2025
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,894
+35.7%
|
-
|
|
Mar 01
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,079
-7.57%
|
$129,318
$42.55 P/Share
|
|
Mar 01
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,949
+6.49%
|
-
|
|
Mar 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,029
-6.41%
|
$85,218
$42.55 P/Share
|
|
Mar 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,686
+15.23%
|
-
|
|
Mar 01
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,566
-3.88%
|
$65,772
$42.55 P/Share
|
|
Mar 01
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,686
+12.35%
|
-
|
|
Mar 01
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,590
-6.52%
|
$66,780
$42.55 P/Share
|
|
Mar 01
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,406
+8.16%
|
-
|
|
Mar 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,537
-6.3%
|
$106,554
$42.55 P/Share
|
|
Mar 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,108
+15.0%
|
-
|
|
Mar 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,042
-4.0%
|
$127,764
$42.55 P/Share
|
|
Mar 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,001
+3.7%
|
-
|
|
Feb 28
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.44%
|
-
|
|
Feb 20
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.63%
|
$5,568
$48.33 P/Share
|
|
Feb 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.49%
|
-
|
|
Feb 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.26%
|
-
|
|
Feb 04
2025
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.84%
|
-
|
|
Feb 01
2025
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,352
-10.65%
|
$384,192
$46.98 P/Share
|
|
Feb 01
2025
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,863
+21.8%
|
-
|
|
Feb 01
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-6.64%
|
$108,606
$46.98 P/Share
|
|
Feb 01
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,617
+15.7%
|
-
|
|
Jan 31
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.46%
|
-
|
|
Jan 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-3.79%
|
$4,292
$37.58 P/Share
|
|
Jan 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.49%
|
-
|
|
Jan 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+7.55%
|
-
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,305
-4.32%
|
$48,285
$37.5 P/Share
|
|
Jan 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,309
+9.87%
|
-
|
|
Jan 15
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,420
-34.99%
|
$237,540
$37.5 P/Share
|